3Leroyer AS, Anfosso F, Lacroix R, et al. Endothelial-derived mi- croparticles: Biological conveyors at the crossroad of inflamma- tion, thrombosis and angiogenesis[J]. Thromb Haemost,2010,104 (3) :456-463.
4Wang JM, Wang Y, Huang JY, et al. C-reactive protein-induced endothelial microparticle generation in HUVECs is related to BH4- dependent NO formation[J]. J Vasc Res,2007,44(3) :241-248.
5Boulanger CM, Amabile N, Guerin AP, et al. In vivo shear stress determines circulating levels of endothelial microparticles in end- stage renal disease[J]. Hypertension, 2007,49(4) : 902-908.
6Piccin A, Murphy WG, Smith OP. Circulating microparticles.. pathophysiology and clinical implications[J]. Blood Rev, 2007,21 (3) :157-171.
7Jimenez JJ, Jy W, Mauro LM, et al. Endothelial cells release phe- notypically and quantitatively distinct micropartieles in activation and apoptosis[J]. Thromb Res, 2003,109(4) : 175-180.
8Wang JM, Su C, Wang Y, et al. Elevated circulating endothelial microparticles and braehial-ankle pulse wave velocity in well-con- trolled hypertensive patients[J]. J Hum Hypertens, 2009,23 (5) : 307-315.
9Wang JM, Huang JY, Wang Y, et al. Increased circulating CD31^+/CD42^- microparticles are associated with impaired sys- temic artery elasticity in healthy subjects[J]. Am J Hypertens, 2007,20(9) :957-964.
10Horstman LL, Jy W, Jimenez JJ, etal. Endothelial mieroparticles as markers of endothelial dysfunction[J].Front Biosei, 2004,9 ( 5- 1) :1118-1135.
